WGU D027 – ADVANCED PATHOPHARMACOLOGICAL
FOUNDATIONS - MSN PROGRAM PREP EXAM QUESTIONS
AND CORRECT VERIFIED ANSWERS WITH RATIONALES
100% GUARANTEED PASS!!
<LATEST VERSION>
Question 1
A 62-year-old patient with long-standing hypertension and type 2 diabetes presents
with microalbuminuria. Which medication class provides the greatest benefit in
slowing progression of diabetic nephropathy?
A. Thiazide diuretics
B. Calcium channel blockers
C. Angiotensin-converting enzyme inhibitors
D. Beta-adrenergic blockers
Correct Answer: C
Rationale:
ACE inhibitors reduce intraglomerular pressure by dilating the efferent arteriole,
which slows progression of diabetic nephropathy and reduces proteinuria.
A: Thiazides improve BP but do not provide renal protective effects.
B: Calcium channel blockers lower BP but lack specific nephroprotection.
D: Beta blockers do not directly protect renal function.
,Question 2
A patient receiving warfarin therapy begins trimethoprim-sulfamethoxazole for a
urinary tract infection. Which outcome is most concerning?
A. Reduced INR due to enzyme induction
B. Increased risk of bleeding
C. Decreased warfarin absorption
D. Subtherapeutic anticoagulation
Correct Answer: B
Rationale:
Trimethoprim-sulfamethoxazole inhibits CYP450 metabolism of warfarin,
increasing INR and bleeding risk.
A: TMP-SMX inhibits rather than induces enzymes.
C: Absorption is not the primary interaction.
D: Anticoagulation becomes excessive, not subtherapeutic.
Question 3
A patient with heart failure with reduced ejection fraction is started on
sacubitril/valsartan. What is the primary mechanism responsible for improved
outcomes?
A. Direct suppression of aldosterone secretion
B. Enhancement of natriuretic peptide effects
C. Increased myocardial contractility
D. Reduced preload through venodilation
Correct Answer: B
Rationale:
Sacubitril inhibits neprilysin, increasing natriuretic peptides, leading to
vasodilation, natriuresis, and reduced cardiac remodeling.
, A: Aldosterone suppression is indirect.
C: It does not act as an inotrope.
D: Preload reduction occurs but is not the primary mechanism.
Question 4
A patient with chronic asthma uses an albuterol inhaler multiple times daily.
Which pharmacologic change best addresses worsening control?
A. Increase albuterol dosing frequency
B. Add inhaled corticosteroid therapy
C. Switch to an anticholinergic inhaler
D. Add oral theophylline
Correct Answer: B
Rationale:
Frequent short-acting beta-agonist use indicates uncontrolled asthma and the need
for inhaled corticosteroids to address airway inflammation.
A: Overuse worsens outcomes.
C: Anticholinergics are adjunctive, not first-line.
D: Theophylline has a narrow therapeutic index and is not preferred.
Question 5
A patient receiving cisplatin chemotherapy develops tinnitus and rising creatinine
levels. These findings reflect toxicity related to:
A. Hepatic microsomal enzyme induction
B. Disruption of cochlear and renal tubular cells
C. Immune-mediated hypersensitivity
D. Altered sodium-potassium ATPase activity
Correct Answer: B
, Rationale:
Cisplatin causes direct nephrotoxicity and ototoxicity due to cellular injury in renal
tubules and cochlear hair cells.
A: Not enzyme-mediated.
C: Not immune driven.
D: This mechanism is associated with digoxin.
Question 6
A patient with atrial fibrillation is prescribed apixaban. Which factor requires the
most careful dose consideration?
A. Body mass index
B. Renal function
C. Serum potassium
D. Liver transaminases
Correct Answer: B
Rationale:
Direct oral anticoagulants are partially renally excreted, making renal function
critical for dosing and bleeding risk.
A: BMI alone does not guide dosing.
C: Potassium levels are unrelated.
D: Mild transaminase elevation does not usually require adjustment.
Question 7
A patient develops a persistent dry cough after starting antihypertensive therapy.
Which mechanism best explains this adverse effect?
A. Bradykinin accumulation
B. Beta-2 receptor stimulation
FOUNDATIONS - MSN PROGRAM PREP EXAM QUESTIONS
AND CORRECT VERIFIED ANSWERS WITH RATIONALES
100% GUARANTEED PASS!!
<LATEST VERSION>
Question 1
A 62-year-old patient with long-standing hypertension and type 2 diabetes presents
with microalbuminuria. Which medication class provides the greatest benefit in
slowing progression of diabetic nephropathy?
A. Thiazide diuretics
B. Calcium channel blockers
C. Angiotensin-converting enzyme inhibitors
D. Beta-adrenergic blockers
Correct Answer: C
Rationale:
ACE inhibitors reduce intraglomerular pressure by dilating the efferent arteriole,
which slows progression of diabetic nephropathy and reduces proteinuria.
A: Thiazides improve BP but do not provide renal protective effects.
B: Calcium channel blockers lower BP but lack specific nephroprotection.
D: Beta blockers do not directly protect renal function.
,Question 2
A patient receiving warfarin therapy begins trimethoprim-sulfamethoxazole for a
urinary tract infection. Which outcome is most concerning?
A. Reduced INR due to enzyme induction
B. Increased risk of bleeding
C. Decreased warfarin absorption
D. Subtherapeutic anticoagulation
Correct Answer: B
Rationale:
Trimethoprim-sulfamethoxazole inhibits CYP450 metabolism of warfarin,
increasing INR and bleeding risk.
A: TMP-SMX inhibits rather than induces enzymes.
C: Absorption is not the primary interaction.
D: Anticoagulation becomes excessive, not subtherapeutic.
Question 3
A patient with heart failure with reduced ejection fraction is started on
sacubitril/valsartan. What is the primary mechanism responsible for improved
outcomes?
A. Direct suppression of aldosterone secretion
B. Enhancement of natriuretic peptide effects
C. Increased myocardial contractility
D. Reduced preload through venodilation
Correct Answer: B
Rationale:
Sacubitril inhibits neprilysin, increasing natriuretic peptides, leading to
vasodilation, natriuresis, and reduced cardiac remodeling.
, A: Aldosterone suppression is indirect.
C: It does not act as an inotrope.
D: Preload reduction occurs but is not the primary mechanism.
Question 4
A patient with chronic asthma uses an albuterol inhaler multiple times daily.
Which pharmacologic change best addresses worsening control?
A. Increase albuterol dosing frequency
B. Add inhaled corticosteroid therapy
C. Switch to an anticholinergic inhaler
D. Add oral theophylline
Correct Answer: B
Rationale:
Frequent short-acting beta-agonist use indicates uncontrolled asthma and the need
for inhaled corticosteroids to address airway inflammation.
A: Overuse worsens outcomes.
C: Anticholinergics are adjunctive, not first-line.
D: Theophylline has a narrow therapeutic index and is not preferred.
Question 5
A patient receiving cisplatin chemotherapy develops tinnitus and rising creatinine
levels. These findings reflect toxicity related to:
A. Hepatic microsomal enzyme induction
B. Disruption of cochlear and renal tubular cells
C. Immune-mediated hypersensitivity
D. Altered sodium-potassium ATPase activity
Correct Answer: B
, Rationale:
Cisplatin causes direct nephrotoxicity and ototoxicity due to cellular injury in renal
tubules and cochlear hair cells.
A: Not enzyme-mediated.
C: Not immune driven.
D: This mechanism is associated with digoxin.
Question 6
A patient with atrial fibrillation is prescribed apixaban. Which factor requires the
most careful dose consideration?
A. Body mass index
B. Renal function
C. Serum potassium
D. Liver transaminases
Correct Answer: B
Rationale:
Direct oral anticoagulants are partially renally excreted, making renal function
critical for dosing and bleeding risk.
A: BMI alone does not guide dosing.
C: Potassium levels are unrelated.
D: Mild transaminase elevation does not usually require adjustment.
Question 7
A patient develops a persistent dry cough after starting antihypertensive therapy.
Which mechanism best explains this adverse effect?
A. Bradykinin accumulation
B. Beta-2 receptor stimulation
